WO2020000068A1 - Surfactant system and sunscreen composition comprising it - Google Patents

Surfactant system and sunscreen composition comprising it Download PDF

Info

Publication number
WO2020000068A1
WO2020000068A1 PCT/BR2018/050212 BR2018050212W WO2020000068A1 WO 2020000068 A1 WO2020000068 A1 WO 2020000068A1 BR 2018050212 W BR2018050212 W BR 2018050212W WO 2020000068 A1 WO2020000068 A1 WO 2020000068A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
composition
ranges
sunscreen
sunscreen composition
Prior art date
Application number
PCT/BR2018/050212
Other languages
French (fr)
Inventor
Bruna Rodrigues SALOMAO
Ludmila Pons CAMARGO
Tassia HANASHIRO
Angeles Clara Fonolla-Moreno
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal filed Critical L'oreal
Priority to BR112020019792-0A priority Critical patent/BR112020019792B1/en
Priority to PCT/BR2018/050212 priority patent/WO2020000068A1/en
Publication of WO2020000068A1 publication Critical patent/WO2020000068A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/062Oil-in-water emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/596Mixtures of surface active compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/61Surface treated
    • A61K2800/62Coated
    • A61K2800/621Coated by inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/65Characterized by the composition of the particulate/core
    • A61K2800/651The particulate/core comprising inorganic material

Definitions

  • the present invention is directed to a new surfactant system for sunscreen compositions, a sunscreen composition with high SPF, the process of manufacturing the composition and its uses.
  • Conventional sunscreen products generally take the form of sunscreen filter actives that are solubilized, emulsified or dispersed in a cosmetically or physiologically acceptable carrier, which is topically applied to the skin.
  • the degree of UV protection afforded by a sunscreen composition is directly related to the amount and type of UV filters contained therein. The higher the amount of UV filters, the greater the degree of UV protection (UVA/UVB).
  • sunscreen compositions must provide good protection against the sun, a measure of which is the Sun Protection Factor (SPF) value, yet have satisfactory sensory perception, such as a smooth but not greasy feel upon application.
  • SPF Sun Protection Factor
  • this combination of properties has been difficult to achieve, particularly because many active sunscreen compounds themselves have an oily or greasy feel, and increasing their content tends to cause the final product to suffer from that effect.
  • sunscreen filters are oil-like and/or oil-soluble materials. High levels of sunscreen filters in sunscreen products render the products less appealing for their greasy skin feel, stickiness, long drying time, and leave shiny residue on the skin after application. The filters also have the tendency to whiten the skin after application and after becoming wet with water or perspiration which is an undesirable attribute.
  • a sunscreen composition having high SPF associated with the unique sensorial described above uses high amounts of ingredients (UV filters) and tends to be instable and ineffective.
  • the inventors succeeded to overcome the problems of the state of the art and surprisingly revealed a stable sunscreen composition with high SPF through the use of a new surfactant system.
  • the present invention is directed to a new surfactant system that provides stable sunscreen compositions with high SPF.
  • the present invention is directed to a sunscreen composition
  • a sunscreen composition comprising (a) a surfactant system, (b) a polylactic acid-based resin (PLA), (c) a mattifying powder and (d) UV filters.
  • the composition of the present invention presents a high level of UV- protection in order to protect the skin from the damages of the sun, easy application, good spreadability and less silicon effect, less white film, less shine, which does not run on high temperature in the face, has an imperceptible touch, gives the ideal balance between hydration and oil control, reduces impurities accumulation, reinforces the barrier against pollution, leaves the facial skin breathing, combines high protection with smoothness to the skin, sweat resistant, prepare the skin for the make-up, renew the skin quality, let the skin breathe, purified skin sensation and soothing effect to the skin. Also, the composition of the present invention is stable over the time.
  • FIG. 1 shows microscopic photos demonstrating the superior stability and robustness of the composition of the present invention (comprising the surfactant system) in view of the composition of the state of the art (without the surfactant system).
  • the present invention is directed to a surfactant system comprising a mixture of surfactants, which comprises:
  • the mixture of at least three stearol derivatives compounds comprises stearic acid, glyrecyl stearate and PEG-100 stearate and stearyl alcohol.
  • the amount of the mixture of at least three stearol derivatives compounds is ranging from about 1 to 30% by weight and preferably from about 2.5 to about 8% by weight, or more preferably from about 3 to about 6% by weight, including all ranges and sub-ranges there between, relative to the total weight of the composition.
  • the mixture of at least three stearol derivatives compounds employs a first surfactant in an amount preferably ranging from about 0.1 to about 10% by weight and preferably from about 0.3 to about 5% by weight, or more preferably from about 0.5 to about 3% by weight, including all ranges and sub-ranges there between, relative to the total weight of the composition.
  • the mixture of at least three stearol derivatives compounds employs a second surfactant in an amount preferably ranging from about 0.05 to about 10% by weight and preferably from about 0.1 to about 6% by weight, or more preferably from about 0.2 to about 3% by weight, including all ranges and sub-ranges therebetween, relative to the total weight of the composition.
  • the mixture of at least three stearol derivatives compounds employs a third surfactant in an amount preferably ranging from about 0.05 to about 10% by weight and preferably from about 0.1 to about 5% by weight, or more preferably from about 0.1 to about 2% by weight, including all ranges and sub-ranges therebetween, relative to the total weight of the composition.
  • the phosphate surfactant is selected from monoalkyl phosphates, potassium cetyl phosphate, dialkyl phosphates, salts of monoalkyl phosphates, salts of dialkyl phosphates, and mixtures thereof. More preferably, the monoalkyl phosphates and dialkyl phosphates comprise one or more linear or branched and aliphatic and/or aromatic alkyl chains having from 8 to 22 carbon atoms.
  • the phosphate surfactant(s) can be neutralized with organic or inorganic bases such as, for example, potassium hydroxide, sodium hydroxide, triethanolamine, arginine, lysine and N-methylglucamine to form the aforementioned salts.
  • organic or inorganic bases such as, for example, potassium hydroxide, sodium hydroxide, triethanolamine, arginine, lysine and N-methylglucamine to form the aforementioned salts.
  • Suitable examples of phosphate surfactants include, but are not limited to, monolauryl phosphate, the potassium salt of dodecyl phosphate, such as the mixture of mono- and diester (predominantly diester), the octyl monoester and the octyl diester of phosphoric acid, the ethoxylated (7 mol. of EO) 2-butyloctanol monoester and the ethoxylated (7 mol.
  • the phosphate surfactant is present in the surfactant system in a range of from about 0.05 to about 10% by weight and preferably from about 0.1 to about 5% by weight, or more preferably from about 0.2 to about 3% by weight, including all ranges and sub-ranges therebetween, relative to the total weight of the composition.
  • the sodium salt of the stearic acid amide is selected from sodium methyl stearoyl taurate.
  • the sodium salt of the stearic acid amide is present in the composition in a range of from about 0.05 to about 10% by weight and preferably from about 0.1 to about 4% by weight, or more preferably from about 0.2 to about 1 % by weight, including all ranges and sub-ranges therebetween, relative to the total weight of the composition.
  • the surfactant system of the invention is used in a sunscreen composition.
  • the sunscreen composition of the present invention comprises:
  • composition according to the invention provides excellent sensorial performance as well as surprisingly high SPF values associated to a strong stability of the composition over time.
  • the pH of the sunscreen composition of the invention is preferably within the range of about 6.0 to about 7.6, more preferably, of about 6.5.
  • the amount of the surfactant system in the sunscreen composition of the invention ranges from about 0.2 to about 8% by weight, or from about 0.3 to about 7% by weight, from about 0.5 to about 5% by weight or from about 0.6 to about 4.5% by weight, including all ranges and sub-ranges therebetween, relative to the total weight of the composition.
  • the amount of the UV filters in the sunscreen composition of the invention ranges from about 3% to about 40% by weight, preferably in an amount of from about 5% to about 25% by weight, and most preferably about 7% to about 18% by weight, based on the total weight of the composition.
  • the amount of the polylactic acid-based resin (PLA) in the sunscreen composition of the invention ranges from about 0.1 to about 3% by weight, or from about 0.2 to about 2% by weight, or from about 0.1 to about 1 % by weight, including all ranges and sub-ranges therebetween, relative to the total weight of the composition.
  • the amount of the mattifying agent in the sunscreen composition of the invention ranges from about 0.01 % to about 10% by weight, preferably in an amount of from about 0.1 % to about 5% by weight, and most preferably about 0.5% to about 4% by weight, based on the total weight of the composition.
  • the sunscreen composition of the present invention may present a Sun Protection Factor ranging from 30 to 80.
  • the sunscreen composition of the present invention may present a Sun Protection Factor of 30, 35, 40, 45, 50, 55, 60, 65, 70 and 80.
  • the sunscreen composition of the present invention may present a Sun Protection Factor of 50.
  • the sunscreen composition of the present invention may present a Sun Protection Factor of 60.
  • the sunscreen composition of the present invention may present a Sun Protection Factor of 70.
  • the sunscreen composition of the present invention may present a Sun Protection Factor of 80.
  • the sunscreen composition of the invention is in the form of an oil in water (O/W) emulsion.
  • the sunscreen composition of the invention can be used as a daily product for the skin.
  • the sunscreen composition of the present invention presents easy application, good spreadability and less silicon effect, less white film, less shine, which does not run on high temperature in the face, has an imperceptible touch, gives the ideal balance between hydration and oil control, reduces impurities accumulation, reinforces the barrier against pollution, leaves the facial skin breathing, combines high protection with smoothness to the skin, sweat resistant, prepare the skin for the make up, renew the skin quality, let the skin breathe, purified skin sensation and soothing effect to the skin. Also, the composition of the present invention is stable over time.
  • the present invention is also related to a process of manufacturing a sunscreen composition for preventing sunburns that provides for the consumer feeling of comfort in extreme conditions of heat and sweat.
  • the present invention is related to the use of a composition for manufacturing a sunscreen for preventing sunburn.
  • the expression“at least” means one or more and thus includes individual components as well as mixtures/combinations.
  • ranges provided are meant to include every specific range within, and combination of sub ranges between, the given ranges.
  • a range from 1 -5 includes specifically 1 , 2, 3, 4 and 5, as well as sub ranges such as 2-5, 3-5, 2-3, 2-4, 1 -4, etc.
  • All ranges and values disclosed herein are inclusive and combinable. For examples, any value or point described herein that falls within a range described herein can serve as a minimum or maximum value to derive a sub-range, etc.
  • the suitable surfactant system of the present invention may comprise additional surfactants that could be chosen among the surfactants described below.
  • Anionic surfactants useful in the invention include, for example, carboxylates (sodium 2-(2-hydroxyalkyloxy)acetate), amino acid derivatives (N- acylglutamates, N-acylglycinates or acylsarcosinates), alkyl sulfates, alkyl ether sulfates and oxyethylenated derivatives thereof, sulfonates, isethionates and N- acylisethionates, taurates and N-acyl N-methyltaurates, sulfosuccinates, alkyl sulfoacetates, phosphates and alkyl phosphates, anionic derivatives of alkyl polyglycoside (acyl-D-galactoside uronate), and mixtures thereof.
  • carboxylates sodium 2-(2-hydroxyalkyloxy)acetate
  • amino acid derivatives N- acylglutamates, N-acylglycinates or acy
  • Non-limiting examples of non-ionic surfactants useful in the invention include, for example, oxyalkylenated (more particularly polyoxyethylenated) fatty acid esters of glycerol; oxyalkylenated fatty acid esters of sorbitan; oxyalkylenated (oxyethylenated and/or oxypropylenated) fatty acid esters; oxyalkylenated (oxyethylenated and/or oxypropylenated) fatty alcohol ethers; sugar esters, for instance sucrose stearate; fatty alcohol ethers of sugars, especially alkyl polyglucosides (APGs) such as decyl glucoside and lauryl glucoside, cetostearyl glucoside optionally as a mixture with cetostearyl alcohol, and also arachidyl glucoside, for example in the form of a mixture of arachidyl alcohol, behenyl alcohol and arachidyl
  • the mixture of the alkyl polyglucoside as defined above with the corresponding fatty alcohol may be in the form of a self-emulsifying composition. Mention may also be made of lecithins and derivatives (e.g. Biophilic), sugar esters and sodium stearoyl lactylate.
  • Non-limiting examples of fatty acids chosen from C12-C22 higher fatty acids such as myristic acid, oleic acid, linoleic acid, linolenic acid, lauric acid, palmitic acid, and mixtures thereof.
  • Non-limiting suitable UV filters of the present invention could be as follows:
  • oil-soluble organic sunscreen ingredient means any organic compound for screening out UV radiation, which can be fully dissolved in molecular form or miscible in an oil phase or which can be dissolved in colloidal form (for example in micellar form) in an oil fatty phase.
  • Non-limiting examples of oil-soluble organic sunscreen ingredients useful in the invention include, for example, cinnamic derivatives; anthranilates; salicylic derivatives; dibenzoylmethane derivatives; camphor derivatives; benzophenone derivatives; diphenylacrylate derivatives; triazine derivatives; benzotriazole derivatives; benzalmalonate derivatives, especially those cited in patent US5624663; benzimidazole derivatives; imidazolines; bis-benzoazolyl derivatives as described in patents EP669323 and US2463264; p-aminobenzoic acid (PABA) derivatives; methylene bis(hydroxyphenylbenzotriazole) derivatives as described in applications US5237071 , US5166355, GB2303549, DE19726184 and EP8931 19; benzoxazole derivatives as described in patent applications EP0832642, EP1027883, EP1300137 and DE10162844; screening polymers and screening silicones such as
  • cinnamic derviatives include, but are not limited to, ethylhexyl methoxycinnamate, isopropyl methoxycinnamate, isoamyl methoxycinnamate, DEA methoxycinnamate, diisopropyl methylcinnamate, glyceryl ethylhexanoate dimethoxycinnamate.
  • Suitable dibenzoylmethane derivatives include, but are not limited to, butyl methoxydibenzoylmethane and isopropyl dibenzoylmethane.
  • suitable salicylic derivatives include, but are not limited to, homosalate, ethylhexyl salicylate, dipropylene glycol salicylate and TEA salicylate.
  • Beta, beta -Diphenylacrylate derivatives
  • Suitable beta, beta -diphenylacrylate derivatives include, but are not limited to, octocrylene and etocrylene.
  • benzophenone derivatives include, but are not limited to, benzophenone-1 , benzophenone-2, benzophenone-3 or oxybenzone, benzophenone-4, benzophenone-5, benzophenone-6, benzophenone-8, benzophenone-9, benzophenone-12, n-hexyl 2-(4-diethylamino-2- hydroxybenzoyl)benzoate +” or as a mixture with octyl methoxycinnamate.
  • Suitable benzylidenecamphor derivatives include, but are not limited to, 3-benzylidene camphor manufactured, 4-methylbenzylidene camphor, polyacrylamidomethyl benzylidene camphor manufactured.
  • Suitable phenylbenzotriazole derivatives include, but are not limited to, drometrizole trisiloxane, methylene bis-benzotriazolyl tetramethylbutyl- phenol, or in micronized form as an aqueous dispersion.
  • triazine derivatives include, but are not limited to, bis-ethylhexyloxyphenol methoxyphenyl triazine, ethylhexyl triazone, diethylhexyl butamido triazone, 2,4,6-tris(dineopentyl 4’-aminobenzalmalonate)-s-triazine, 2,4,6- tris(diisobutyl 4’-aminobenzalmalonate)-S triazine, 2,4-bis(dineopentyl 4'- aminobenzalmalonate)-6-(n-butyl 4'-aminobenzoate)-s-triazine, symmetrical triazine screening agents described in patent US 6,225,467, patent application WO 2004/085412 (see compounds 6 and 9) or the document "Symmetrical Triazine Derivatives" IP.COM Journal, IP.COM Inc., West Henrietta, NY,
  • An example of a suitable anthranilic derivative includes, but is not limited to, menthyl anthranilate.
  • An example of a suitable imidazoline derivative includes, but is not limited to, ethylhexyl dimethoxybenzylidene dioxoimidazoline propionate.
  • Benzalmalonate derivative includes, but is not limited to, polyorganosiloxane containing benzalmalonate functions, for instance polysilicone-15.
  • An example of a suitable 4,4-diarylbutadiene derivative includes, but is not limited to, 1 -Dicarboxy(2,2’-dimethylpropyl)-4, 4-diphenyl-butadiene.
  • benzoxazole derivative includes, but is not limited to, 2,4-bis[5-(1 -dimethylpropyl)benzoxazol-2-yl-(4-phenyl)imino]-6-(2-ethylhexyl) imino-1 ,3,5-triazine, and mixtures thereof.
  • the oil-soluble organic sunscreen ingredient will be chosen from butyl methoxydibenzoylmethane, ethylhexyl salicylate, ethylhexyl triazone, octocrylene, drometrizole trisiloxane, bis-ethylhexyloxyphenol methoxyphenyl triazine, and mixtures thereof.
  • the oil-soluble organic sunscreen ingredient is preferably present in the composition according to the invention in an amount of from about 3% to about 25% by weight, preferably in an amount of from about 5% to about 20% by weight, and most preferably about 7% to about 18% by weight, based on the total weight of the composition.
  • The“water-soluble organic sunscreen ingredient” means any organic compound for screening out UV radiation, which can be fully dissolved in molecular form or miscible in a liquid aqueous phase or which can be dissolved in colloidal form (for example in micellar form) in a liquid aqueous phase.
  • Non-limiting examples of water-soluble organic sunscreen ingredients useful in the invention include, for example, terephthalylidene dicamphor sulfonic acid (Ecamsule), phenylbenzimidazole sulfonic acid (Ensulizole), benzophenone-4, aminobenzoic acid (PABA), 4-Bis(polyethoxy)-para-aminobenzoic acid polyethoxyethyl ester (PEG-25 PABA), camphor benzalkonium methosulfate, methylene bis-benzotriazolyl tetramethylbutylphenol (Bisoctrizole), disodium phenyl dibenzimidazole tetrasulfonate (Bisdisulizole disodium), and tris-biphenyl triazine; their derivatives and corresponding salts; naphthalene bisimide derivatives such as those described in European patent application EP1990372 A2, the entire contents of which is hereby incorporated
  • the salts of the compounds that may be used according to the invention are chosen in particular from salts of alkali metals, for example sodium or potassium; salts of alkaline-earth metals, for example calcium, magnesium or strontium; metal salts, for example zinc, aluminum, manganese or copper; salts of ammonium of formula NH4+; quaternary ammonium salts; salts of organic amines, for instance salts of methylamine, dimethylamine, trimethylamine, triethylamine, ethylamine, 2- hydroxyethylamine, bis(2-hydroxyethyl)amine or tris(2-hydroxyethyl)amine; lysine or arginine salts.
  • Salts chosen from sodium, potassium, magnesium, strontium, copper, manganese or zinc salts are preferably used.
  • the sodium salt is preferably used.
  • the water-soluble organic sunscreen ingredient will be chosen from terephthalylidene dicamphor sulfonic acid, methylene bis-benzotriazolyl tetramethylbutylphenol, and mixtures thereof.
  • the water-soluble organic sunscreen ingredient is preferably present in the composition according to the invention in an amount of from about 0.1 % to about 10% by weight, preferably in an amount of from about 0.5% to about 8% by weight, and most preferably about 1 % to about 7% by weight, based on the total weight of the composition.
  • the “silica-coated titanium dioxide sunscreen ingredient” means spherical beads which are formed by encapsulating titanium dioxide particles in silica.
  • Non-limiting examples of silica coated titanium dioxide sunscreen ingredients useful in the invention include, for example, titanium dioxide coated with silica, such as name silica (and) titanium dioxide having a composition of silica:titanium dioxide of about 55:45 and having a particle size from about 2 microns to about 7 microns.
  • silica coated titanium dioxide sunscreen ingredients useful in the invention include, for example, titanium dioxide coated with silica, such as name silica (and) titanium dioxide having a composition of silica:titanium dioxide of about 55:45 and having a particle size from about 2 microns to about 7 microns.
  • the silica-coated titanium dioxide sunscreen ingredient is preferably present in the composition according to the invention in an amount of from about 1 % to about 10% by weight, preferably in an amount of from about 2% to about 10% by weight, and most preferably about 5% to about 10% by weight, based on the total weight of the composition.
  • the suitable UV filter system of the present invention comprises terephthalylidene dicamphor sulfonic acid, octocrylene and butyl methoxydibenzoylmethane sulfonic acid.
  • the concentration of the mixture of sunscreen/UV filters in the system may be between about 3% to about 40%, preferably between about 5% to about 25% and even more preferably between about 7 to about 18% by weight of the total weight of the composition.
  • compositions of the invention comprise porous microparticles of a polylactic acid-based resin, sometimes referred to herein as “polylactic acid microparticles” or“PLA.”
  • the PLA microparticles may have an enthalpy of fusion of 5 J/g or more, preferably 10 J/g or more, more preferably 20 J/g or more, and most preferably 30 J/g or more. Further, the upper limit is preferably 100 J/g or less, although it is not limited in particular.
  • Enthalpy of fusion refers to a value calculated from a peak area, which shows heat capacity of fusion at approximately 160°C, in a differential scanning calorimetry (DSC) where a temperature is raised to 200°C with the temperature rise of 20°C per minute.
  • Enthalpy of fusion can be adjusted by controlling the co-polymerization ratio (L/D) between L-lactic acid and D-lactic acid which constitute the polylactic acid- based resin.
  • L/D ratio is 95/5 or more, enthalpy of fusion becomes 5 J/g or more and the polylactic acid-based resin becomes crystalline.
  • the co-polymerization ratio of L-lactic acid is high because higher ratios facilitate crystallization.
  • L/D is more preferably 97/3 or more, and most preferably 98/2 or more.
  • L/D is 100/0 or less.
  • optical isomers such as L and D have molecular structures that are mirror images of each other and physical properties are not different, enthalpy of fusion remains unchanged when the above-described L/D is substituted with D/L and consequently suitable resins include ones in which L/D is substituted with D/L.
  • the polylactic acid-based resin may contain copolymerization ingredients other than lactic acid.
  • the other copolymerization ingredient units can be, for example, a multivalent carboxylic acid, a polyhydric alcohol, a hydroxycarboxylic acid or a lactone.
  • Exemplary multivalent carboxylic acids include oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, azelaic acid, sebacic acid, dodecanedioic acid, fumaric acid, cyclohexanedicarboxylic acid, terephthalic acid, isophthalic acid, phthalic acid, 2,6-naphthalenedicarboxylic acid, anthracene dicarboxylic acid, 5- sodium sulfoisophthalic acid and 5-tetrabutyl phosphonium sulfoisophthalic acid.
  • Exemplary polyhydric alcohols include ethylene glycol, propylene glycol, butanediol, heptanediol, hexanediol, octanediol, nonanediol, decanediol, 1 ,4- cyclohexanedimethanol, neopentyl glycol, glycerin, pentaerythritol, bisphenol A, an aromatic polyhydric alcohol produced by an addition reaction of ethylene oxide to a bisphenol, diethylene glycol, triethylene glycol, polyethylene glycol, polypropylene glycol and polytetramethylene glycol.
  • Exemplary hydroxycarboxylic acids include glycolic acid, 3-hydroxybutyric acid, 4-hydroxybutyric acid, 4-hydroxyvaleric acid, 6- hydroxycaproic acid and hydroxybenzoic acid.
  • Exemplary lactones include glycolide, e-caprolactone glycolide, e-caprolactone, b-propiolactone, d-butyrolactone, b- butyrolactone, g-butyrolactone, pivalolactone and d-valerolactone.
  • the volume content of the other copolymerization units is preferably 30 mol % or less, more preferably 20 mol % or less, further more preferably 10 mol % or less, most preferably 5 mol % or less, relative to the total monomer units of the polylactic acid-based resin as 100 mol%.
  • the lower limit of weight average molecular mass of the polylactic acid-based resin is preferably 10,000 or more, more preferably 50,000 or more, further more preferably 100,000 or more, most preferably 200,000 or more.
  • the upper limit of weight average molecular mass is preferably 1 ,000,000 or less.
  • the weight average molecular mass referred to herein is weight average molecular mass in terms of polymethyl methacrylate (PMMA), measured by gel permeation chromatography (GPC) using hexafluoroisopropanol as a solvent.
  • the PLA microparticles may have a number average particle diameter of 90 pm or less, preferably 50 pm or less, more preferably 30 pm or less. This improves smoothness. Further, in uses such as cosmetics, because coagulation of particles tends to occur when the number average particle diameter is too small, the lower limit of the number average particle diameter is generally 1 pm or more, preferably more than 1 pm, more preferably 2 pm or more, most preferably 3 pm or more.
  • the particle diameter distribution index is preferably 2 or less in order to improve flow of the particles and impart a smoother touch.
  • the upper limit of the particle diameter distribution index is preferably 1 .5 or less, more preferably 1 .3 or less, most preferably 1 .2 or less. Further, the lower limit is 1 in theory.
  • the above-described number average particle diameter of polylactic acid-based resin microparticles having porous shapes can be calculated by measuring diameters of 100 random particles in a scanning electron microscope image and computing the arithmetic average thereof. If a shape of a particle in the SEM image is not a perfect circle, for example, an ellipse, the maximum diameter of the particle is used as its diameter. To measure the particle diameter precisely, the measurement is carried out with a magnification of at least 1000 times or more, preferably with a magnification of 5000 times or more.
  • the particle diameter distribution index is calculated on the basis of the conversion equations described below, using measurements of the particle diameters obtained by measurement described above:
  • Ri particle diameter of single particle
  • Dn number average particle diameter
  • Dv volume average particle diameter
  • PDI particle diameter distribution index
  • linseed oil absorption capacity as an indirect index, which is defined in pigment test methods such as Japan Industrial Standards (Refined Linseed Oil Method, JIS K 5101 ).
  • the lower limit of linseed oil capability is preferably 90 mL/100 g or more, more preferably 100 mL/100 g or more, further more preferably 120 mL/100 g or more, particularly preferably 150 mL/100 g or more, remarkably preferably 200 mL/100 g or more, most preferably 300 mL/100 g or more.
  • the upper limit of linseed oil absorption capability is preferably 1000 mL/100 g or less.
  • the above-described porous microparticles of polylactic acid-based resin have enthalpy of fusion of 5 J/g or more. Higher enthalpy of fusion brings higher crystallization tendency and, as a result, heat resistance and durability tend to become high.
  • the lower limit of enthalpy of fusion is preferably 10 J/g or more, more preferably 20 J/g or more, further more preferably 30 J/g or more. Further, the upper limit is preferably 100 J/g or less.
  • Enthalpy of fusion can be calculated from an area of peak showing thermal capacity of fusion at approximately 160°C in Differential Scanning calorimetry (DSC) in which a temperature is raised to 200°C with a temperature rise of 20°C per minute.
  • DSC Differential Scanning calorimetry
  • Sphericity of the above-described porous microparticles of polylactic acid-based resin is preferably 80 or more, more preferably 85 or more, furthermore preferably 90 or more, particularly preferably 92 or more, most preferably 95 or more. Further, in theory, the upper limit is 100. When sphericity is within the above-described range, it becomes possible to achieve an improvement in quality such as slidability. The sphericity is calculated by observing particles by a scanning electron microscope, measuring both the longest diameters and the shortest diameters of 30 random particles and subsequently substituting the measurements into the equation described below:
  • S Sphericity
  • Ds the shortest diameter of single particle
  • DL the longest diameter of single particle.
  • mattifying powder means a powder which absorbs sebum and provides a mattifying effect to the skin.
  • Non-limiting examples of mattifying powders useful in the invention include, for example, modified starches, polyamide powders, hydrophobic silica aerogel particles, acrylic polymer powders, elastomeric silicone powders, clays, and mixtures thereof.
  • Modified starches useful in the invention include, for example, those known under the INCI names aluminum starch octenylsuccinate, sodium starch octenylsuccinate, calcium starch octenylsuccinate, and mixtures thereof.
  • Polyamide powders useful in the invention include, for example, those known under the INCI name nylon-12, nylon-6, and mixtures thereof.
  • hydrophobic silica means any silica whose surface is treated with silylating agents, for example halogenated silanes such as alkylchlorosilanes, siloxanes, in particular dimethylsiloxanes such as hexamethyldisiloxane, or silazanes, so as to functionalize the OH groups with silyl groups Si-Rn, for example trimethylsilyl groups.
  • silylating agents for example halogenated silanes such as alkylchlorosilanes, siloxanes, in particular dimethylsiloxanes such as hexamethyldisiloxane, or silazanes
  • Hydrophobic silica aerogel particles useful in the invention are preferably particles surface-modified with trimethylsilyl groups known under the INCI name silica silylate and include, for example, the aerogel, the particles of which have a mean size of about 1000 microns and a specific surface area per unit of mass ranging from 600 to 800 m 2 /g.
  • a hydrophobic silica aerogel particle is the aerogel, the particles of which have a mean size ranging from 5-15 microns and a specific surface area per unit of mass ranging from 600 to 800 m 2 /g.
  • Acrylic polymer powders useful in the invention include, for example, acrylic polymer powders such as methyl methacrylate crosspolymer.
  • Clays useful in the invention include, for example, clays of the smectite family such as montmorillonites, hectorites, bentonites, beidellites and saponites, and also of the vermiculite, stevensite and chlorite families.
  • Non-limiting examples of clays usefil in the invention include, for example, synthetic hectorites (also known as laponites), these products are sodium magnesium silicates and in particular sodium lithium magnesium silicates; bentonites, magnesium aluminium silicates, especially hydrated, or calcium silicates and especially the product in synthetic form.
  • the mattifying powders will be chosen from aluminum starch octenylsuccinate, nylon-12, silica silylate, methyl methacrylate crosspolymer, and mixtures thereof.
  • composition of the invention may further comprise any usual cosmetically acceptable ingredient, which may be chosen especially from such as additional sunscreens, perfume/fragrance, preserving agents, solvents, actives, surfactants, fatty compounds, vitamins, fillers, silicones, polymers, pigments and mixtures thereof.
  • Non-limiting example of preserving agent which can be used in accordance with the invention include phenoxyethanol.
  • Suitable fillers of the invention could be as examples of oil-absorbing fillers: mica, silica, zea may (corn) starch, magnesium oxide, nylon-12, nylon-66, cellulose, polyethylene, talc, talc (and) methicone, talc (and) dimethicone, perlite, sodium silicate, pumice, ptfe, polymethyl methacrylate, oryza sativa (rice) starch, aluminum starch octenylsuccinate, potato starch modified, alumina, silica silylate, calcium sodium borosilicate, magnesium carbonate, hydrated silica, dimethicone/vinyl dimethicone crosspolymer, sodium carboxylmethyl starch.
  • mica, silica, zea may (corn) starch, magnesium oxide, nylon-12, nylon-66, cellulose, polyethylene, talc, talc (and) methicone, talc (and) dimethicone, perlite, sodium si
  • Suitable solvents include, but are not limited to water, alcohols, glycols and polyols such as glycerin, caprylyl glycol, pentylene glycol, propylene glycol, butylene glycol, and mixtures thereof.
  • the solvent is present in a concentration from about 15 to 00% by weight, or from about 20 to about 80% by weight, or from about 30 to about 70% by weight, or from about 35 to about 75% by weight, or preferably from about 40 to about 70% by weight, and more preferably from about 45 to about 65% by weight, including ranges and sub-ranges there between, based on the total weight of the combinations and/or compositions of the present disclosure.
  • Suitable additional actives include, but are not limited to, disodium EDTA, triethanolamine, and mixtures thereof.
  • surfactants may also be used in the compositions of the present invention non-limiting examples of surfactants suitable for use are fatty acids, glyceryl esters in addition to glyceryl stearate, alkoxylated fatty alcohols, such as stearic acid, laureth-12, glyceryl isostearate, disodium stearoyl glutamate, potassium cetyl phosphate, poloxamer 338, sodium methyl stearoyl taurate and mixtures thereof.
  • fatty acids such as stearic acid, laureth-12, glyceryl isostearate, disodium stearoyl glutamate, potassium cetyl phosphate, poloxamer 338, sodium methyl stearoyl taurate and mixtures thereof.
  • glyceryl esters in addition to glyceryl stearate
  • alkoxylated fatty alcohols such as stearic acid, laureth-12, glyceryl isostearate, disodium
  • Exemplary fat or oil materials include, but are not limited to, esters, fatty acids, synthetic oils, and hydrocarbons/paraffins, such as stearyl alcohol, myristic acid, palmitic acid silicones mineral oil, plant/vegetable oils, and mixtures thereof.
  • Non-limiting example of vitamins suitable for the composition of the present invention includes tocopherol.
  • fatty compounds suitable for the present invention include diisopropyl sebacate, isononyl isononanoate and stearyl alcohol.
  • Exemplary of polymers include, but not limited to, ammonium acryloyldimethyltaurate/vp copolymer and acrylates/Cio-30 alkyl acrylate crosspolymer.
  • the additional ingredients may represent from 60% to 85%, such as from 60% to 82% or such as from 65 to 80% by weight of the total weight of the composition.
  • a suitable composition of the invention is as Examples 1 to 3 and Example 4 is considered the closest prior art, as follows:
  • composition of the present invention comprising the surfactant system
  • FIG. 1 shows a superior stability and robustness of the composition of the present invention (comprising the surfactant system) in view of the composition of the state of the art (without the surfactant system), as showed by FIG. 1.

Abstract

The present invention is directed to a new surfactant system for sunscreen compositions, a sunscreen composition with high SPF, the process of manufacturing the composition and its uses. Also, the composition of the present invention presents easy application, good spreadability and less silicon effect, less white film, less shine, which does not run on high temperature in the face, has an imperceptible touch, gives the ideal balance between hydration and oil control, reduces impurities accumulation, reinforces the barrier against pollution, leaves the facial skin breathing, combines high protection with smoothness to the skin, sweat resistant, prepare the skin for the make-up, renew the skin quality, let the skin breathe, purified skin sensation and soothing effect to the skin. Also, the composition of the present invention is stable over the time.

Description

SURFACTANT SYSTEM, SUNSCREEN COMPOSITION, USE OF A SUNSCREEN COMPOSITION AND PROCESS OF MANUFACTURING THE SUNSCREEN
COMPOSITION FIELD OF THE INVENTION
The present invention is directed to a new surfactant system for sunscreen compositions, a sunscreen composition with high SPF, the process of manufacturing the composition and its uses.
BACKGROUND OF THE INVENTION
Conventional sunscreen products generally take the form of sunscreen filter actives that are solubilized, emulsified or dispersed in a cosmetically or physiologically acceptable carrier, which is topically applied to the skin.
The degree of UV protection afforded by a sunscreen composition is directly related to the amount and type of UV filters contained therein. The higher the amount of UV filters, the greater the degree of UV protection (UVA/UVB).
Particularly, sunscreen compositions must provide good protection against the sun, a measure of which is the Sun Protection Factor (SPF) value, yet have satisfactory sensory perception, such as a smooth but not greasy feel upon application. However, this combination of properties has been difficult to achieve, particularly because many active sunscreen compounds themselves have an oily or greasy feel, and increasing their content tends to cause the final product to suffer from that effect.
Also, most organic sunscreen filters are oil-like and/or oil-soluble materials. High levels of sunscreen filters in sunscreen products render the products less appealing for their greasy skin feel, stickiness, long drying time, and leave shiny residue on the skin after application. The filters also have the tendency to whiten the skin after application and after becoming wet with water or perspiration which is an undesirable attribute.
Also, considering the great amount of sunscreen filters in the O/W emulsion, it tends to be instable.
Therefore, it is desired a stable sunscreen composition with high SPF associated with easy application, good spreadability and less silicon effect, less white film, less shine, which does not run on high temperature in the face, has an imperceptible touch, gives the ideal balance between hydration and oil control, reduces impurities accumulation, reinforces the barrier against pollution, leaves the facial skin breathing, combines high protection with smoothness to the skin, sweat resistant, prepare the skin for the make-up, renew the skin quality, let the skin breathe, purified skin sensation and soothing effect to the skin.
The challenge of formulating a sunscreen composition having high SPF associated with the unique sensorial described above is that such composition uses high amounts of ingredients (UV filters) and tends to be instable and ineffective.
Thus, the inventors succeeded to overcome the problems of the state of the art and surprisingly revealed a stable sunscreen composition with high SPF through the use of a new surfactant system.
SUMMARY OF THE INVENTION
The present invention is directed to a new surfactant system that provides stable sunscreen compositions with high SPF.
Also, the present invention is directed to a sunscreen composition comprising (a) a surfactant system, (b) a polylactic acid-based resin (PLA), (c) a mattifying powder and (d) UV filters.
The composition of the present invention presents a high level of UV- protection in order to protect the skin from the damages of the sun, easy application, good spreadability and less silicon effect, less white film, less shine, which does not run on high temperature in the face, has an imperceptible touch, gives the ideal balance between hydration and oil control, reduces impurities accumulation, reinforces the barrier against pollution, leaves the facial skin breathing, combines high protection with smoothness to the skin, sweat resistant, prepare the skin for the make-up, renew the skin quality, let the skin breathe, purified skin sensation and soothing effect to the skin. Also, the composition of the present invention is stable over the time.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows microscopic photos demonstrating the superior stability and robustness of the composition of the present invention (comprising the surfactant system) in view of the composition of the state of the art (without the surfactant system).
DETAILED DESCRIPTION OF THE INVENTION
In an embodiment, the present invention is directed to a surfactant system comprising a mixture of surfactants, which comprises:
(i) a mixture of at least three stearol derivatives compounds;
(ii) a phosphate surfactant;
(iii) sodium salt of the stearic acid amide. In a preferred embodiment, the mixture of at least three stearol derivatives compounds comprises stearic acid, glyrecyl stearate and PEG-100 stearate and stearyl alcohol.
In a preferred embodiment, the amount of the mixture of at least three stearol derivatives compounds is ranging from about 1 to 30% by weight and preferably from about 2.5 to about 8% by weight, or more preferably from about 3 to about 6% by weight, including all ranges and sub-ranges there between, relative to the total weight of the composition.
The mixture of at least three stearol derivatives compounds employs a first surfactant in an amount preferably ranging from about 0.1 to about 10% by weight and preferably from about 0.3 to about 5% by weight, or more preferably from about 0.5 to about 3% by weight, including all ranges and sub-ranges there between, relative to the total weight of the composition.
In a preferred embodiment, the mixture of at least three stearol derivatives compounds employs a second surfactant in an amount preferably ranging from about 0.05 to about 10% by weight and preferably from about 0.1 to about 6% by weight, or more preferably from about 0.2 to about 3% by weight, including all ranges and sub-ranges therebetween, relative to the total weight of the composition.
In a preferred embodiment, the mixture of at least three stearol derivatives compounds employs a third surfactant in an amount preferably ranging from about 0.05 to about 10% by weight and preferably from about 0.1 to about 5% by weight, or more preferably from about 0.1 to about 2% by weight, including all ranges and sub-ranges therebetween, relative to the total weight of the composition.
In a preferred embodiment, the phosphate surfactant is selected from monoalkyl phosphates, potassium cetyl phosphate, dialkyl phosphates, salts of monoalkyl phosphates, salts of dialkyl phosphates, and mixtures thereof. More preferably, the monoalkyl phosphates and dialkyl phosphates comprise one or more linear or branched and aliphatic and/or aromatic alkyl chains having from 8 to 22 carbon atoms. According to preferred embodiments, the phosphate surfactant(s) can be neutralized with organic or inorganic bases such as, for example, potassium hydroxide, sodium hydroxide, triethanolamine, arginine, lysine and N-methylglucamine to form the aforementioned salts.
Suitable examples of phosphate surfactants include, but are not limited to, monolauryl phosphate, the potassium salt of dodecyl phosphate, such as the mixture of mono- and diester (predominantly diester), the octyl monoester and the octyl diester of phosphoric acid, the ethoxylated (7 mol. of EO) 2-butyloctanol monoester and the ethoxylated (7 mol. of EO) 2-butyloctanol diester of phosphoric acid, the potassium or triethanolamine salts of monoalkyl (C12-C13) phosphate, potassium lauryl phosphate, such as the product as a 40% aqueous solution, potassium cetyl phosphate, and the mixtures of these surfactants.
The phosphate surfactant is present in the surfactant system in a range of from about 0.05 to about 10% by weight and preferably from about 0.1 to about 5% by weight, or more preferably from about 0.2 to about 3% by weight, including all ranges and sub-ranges therebetween, relative to the total weight of the composition.
In a preferred embodiment, the sodium salt of the stearic acid amide is selected from sodium methyl stearoyl taurate.
The sodium salt of the stearic acid amide is present in the composition in a range of from about 0.05 to about 10% by weight and preferably from about 0.1 to about 4% by weight, or more preferably from about 0.2 to about 1 % by weight, including all ranges and sub-ranges therebetween, relative to the total weight of the composition.
In a preferred embodiment, the surfactant system of the invention is used in a sunscreen composition.
The sunscreen composition of the present invention comprises:
(a) a surfactant system;
(b) UV filters;
(c) a polylactic acid-based resin (PLA); and
(d) a mattifying powder.
The composition according to the invention provides excellent sensorial performance as well as surprisingly high SPF values associated to a strong stability of the composition over time.
The pH of the sunscreen composition of the invention is preferably within the range of about 6.0 to about 7.6, more preferably, of about 6.5.
In an embodiment, the amount of the surfactant system in the sunscreen composition of the invention ranges from about 0.2 to about 8% by weight, or from about 0.3 to about 7% by weight, from about 0.5 to about 5% by weight or from about 0.6 to about 4.5% by weight, including all ranges and sub-ranges therebetween, relative to the total weight of the composition. The amount of the UV filters in the sunscreen composition of the invention ranges from about 3% to about 40% by weight, preferably in an amount of from about 5% to about 25% by weight, and most preferably about 7% to about 18% by weight, based on the total weight of the composition.
The amount of the polylactic acid-based resin (PLA) in the sunscreen composition of the invention ranges from about 0.1 to about 3% by weight, or from about 0.2 to about 2% by weight, or from about 0.1 to about 1 % by weight, including all ranges and sub-ranges therebetween, relative to the total weight of the composition.
The amount of the mattifying agent in the sunscreen composition of the invention ranges from about 0.01 % to about 10% by weight, preferably in an amount of from about 0.1 % to about 5% by weight, and most preferably about 0.5% to about 4% by weight, based on the total weight of the composition.
In a preferred embodiment, the sunscreen composition of the present invention may present a Sun Protection Factor ranging from 30 to 80.
In various embodiments, the sunscreen composition of the present invention may present a Sun Protection Factor of 30, 35, 40, 45, 50, 55, 60, 65, 70 and 80.
In an embodiment, the sunscreen composition of the present invention may present a Sun Protection Factor of 50.
In an embodiment, the sunscreen composition of the present invention may present a Sun Protection Factor of 60.
In an embodiment, the sunscreen composition of the present invention may present a Sun Protection Factor of 70.
In an embodiment, the sunscreen composition of the present invention may present a Sun Protection Factor of 80.
The sunscreen composition of the invention is in the form of an oil in water (O/W) emulsion.
The sunscreen composition of the invention can be used as a daily product for the skin.
The sunscreen composition of the present invention presents easy application, good spreadability and less silicon effect, less white film, less shine, which does not run on high temperature in the face, has an imperceptible touch, gives the ideal balance between hydration and oil control, reduces impurities accumulation, reinforces the barrier against pollution, leaves the facial skin breathing, combines high protection with smoothness to the skin, sweat resistant, prepare the skin for the make up, renew the skin quality, let the skin breathe, purified skin sensation and soothing effect to the skin. Also, the composition of the present invention is stable over time.
The present invention is also related to a process of manufacturing a sunscreen composition for preventing sunburns that provides for the consumer feeling of comfort in extreme conditions of heat and sweat.
In another preferred embodiment, the present invention is related to the use of a composition for manufacturing a sunscreen for preventing sunburn.
Terms
As used herein, the expression“at least” means one or more and thus includes individual components as well as mixtures/combinations.
Other than in the operating examples, or where otherwise indicated, all numbers expressing quantities of ingredients and/or reaction conditions are to be understood as being modified in all instances by the term“about,” meaning within +/- 5% of the indicated number.
As used herein, all ranges provided are meant to include every specific range within, and combination of sub ranges between, the given ranges. Thus, a range from 1 -5, includes specifically 1 , 2, 3, 4 and 5, as well as sub ranges such as 2-5, 3-5, 2-3, 2-4, 1 -4, etc. All ranges and values disclosed herein are inclusive and combinable. For examples, any value or point described herein that falls within a range described herein can serve as a minimum or maximum value to derive a sub-range, etc.
Additional Surfactants
The suitable surfactant system of the present invention may comprise additional surfactants that could be chosen among the surfactants described below.
Anionic surfactants useful in the invention include, for example, carboxylates (sodium 2-(2-hydroxyalkyloxy)acetate), amino acid derivatives (N- acylglutamates, N-acylglycinates or acylsarcosinates), alkyl sulfates, alkyl ether sulfates and oxyethylenated derivatives thereof, sulfonates, isethionates and N- acylisethionates, taurates and N-acyl N-methyltaurates, sulfosuccinates, alkyl sulfoacetates, phosphates and alkyl phosphates, anionic derivatives of alkyl polyglycoside (acyl-D-galactoside uronate), and mixtures thereof.
Non-limiting examples of non-ionic surfactants useful in the invention include, for example, oxyalkylenated (more particularly polyoxyethylenated) fatty acid esters of glycerol; oxyalkylenated fatty acid esters of sorbitan; oxyalkylenated (oxyethylenated and/or oxypropylenated) fatty acid esters; oxyalkylenated (oxyethylenated and/or oxypropylenated) fatty alcohol ethers; sugar esters, for instance sucrose stearate; fatty alcohol ethers of sugars, especially alkyl polyglucosides (APGs) such as decyl glucoside and lauryl glucoside, cetostearyl glucoside optionally as a mixture with cetostearyl alcohol, and also arachidyl glucoside, for example in the form of a mixture of arachidyl alcohol, behenyl alcohol and arachidyl glucoside. According to one particular embodiment of the invention, the mixture of the alkyl polyglucoside as defined above with the corresponding fatty alcohol may be in the form of a self-emulsifying composition. Mention may also be made of lecithins and derivatives (e.g. Biophilic), sugar esters and sodium stearoyl lactylate.
Non-limiting examples of fatty acids chosen from C12-C22 higher fatty acids, such as myristic acid, oleic acid, linoleic acid, linolenic acid, lauric acid, palmitic acid, and mixtures thereof.
UV Filters
Non-limiting suitable UV filters of the present invention could be as follows:
Oil-soluble organic sunscreen ingredient
The “oil-soluble organic sunscreen ingredient” means any organic compound for screening out UV radiation, which can be fully dissolved in molecular form or miscible in an oil phase or which can be dissolved in colloidal form (for example in micellar form) in an oil fatty phase.
Non-limiting examples of oil-soluble organic sunscreen ingredients useful in the invention include, for example, cinnamic derivatives; anthranilates; salicylic derivatives; dibenzoylmethane derivatives; camphor derivatives; benzophenone derivatives; diphenylacrylate derivatives; triazine derivatives; benzotriazole derivatives; benzalmalonate derivatives, especially those cited in patent US5624663; benzimidazole derivatives; imidazolines; bis-benzoazolyl derivatives as described in patents EP669323 and US2463264; p-aminobenzoic acid (PABA) derivatives; methylene bis(hydroxyphenylbenzotriazole) derivatives as described in applications US5237071 , US5166355, GB2303549, DE19726184 and EP8931 19; benzoxazole derivatives as described in patent applications EP0832642, EP1027883, EP1300137 and DE10162844; screening polymers and screening silicones such as those described especially in patent application WO 93/04665; dimers derived from alkyl- styrene such as those described in patent application DE 19855649; 4,4- diarylbutadienes such as those described in patent applications EP0967200, DE19746654, DE19755649, EP-A-1008586, EP1 133980 and EP1 133981 , merocyanine derivatives such as those described in patent applications WO 04/006878, WO 05/058269 and WO 06/032741 ; and mixtures thereof, the entire contents of the patents and patent applications being incorporated by reference in their entirety.
As examples of other suitable oil-soluble organic sunscreen ingredients, mention may be made of those denoted hereinbelow under their INCI name:
Cinnamic derivatives:
Examples of suitable cinnamic derviatives include, but are not limited to, ethylhexyl methoxycinnamate, isopropyl methoxycinnamate, isoamyl methoxycinnamate, DEA methoxycinnamate, diisopropyl methylcinnamate, glyceryl ethylhexanoate dimethoxycinnamate.
Dibenzoylmethane derivatives:
Examples of suitable dibenzoylmethane derivatives include, but are not limited to, butyl methoxydibenzoylmethane and isopropyl dibenzoylmethane.
Salicylic derivatives:
Examples of suitable salicylic derivatives include, but are not limited to, homosalate, ethylhexyl salicylate, dipropylene glycol salicylate and TEA salicylate.
Beta, beta -Diphenylacrylate derivatives:
Examples of suitable beta, beta -diphenylacrylate derivatives include, but are not limited to, octocrylene and etocrylene.
Benzophenone derivatives:
Examples of suitable benzophenone derivatives include, but are not limited to, benzophenone-1 , benzophenone-2, benzophenone-3 or oxybenzone, benzophenone-4, benzophenone-5, benzophenone-6, benzophenone-8, benzophenone-9, benzophenone-12, n-hexyl 2-(4-diethylamino-2- hydroxybenzoyl)benzoate +” or as a mixture with octyl methoxycinnamate.
Benzylidenecamphor derivatives:
Examples of suitable benzylidenecamphor derivatives include, but are not limited to, 3-benzylidene camphor manufactured, 4-methylbenzylidene camphor, polyacrylamidomethyl benzylidene camphor manufactured.
Phenylbenzotriazole derivatives:
Examples of suitable phenylbenzotriazole derivatives include, but are not limited to, drometrizole trisiloxane, methylene bis-benzotriazolyl tetramethylbutyl- phenol, or in micronized form as an aqueous dispersion.
Triazine derivatives:
Examples of suitable triazine derivatives include, but are not limited to, bis-ethylhexyloxyphenol methoxyphenyl triazine, ethylhexyl triazone, diethylhexyl butamido triazone, 2,4,6-tris(dineopentyl 4’-aminobenzalmalonate)-s-triazine, 2,4,6- tris(diisobutyl 4’-aminobenzalmalonate)-S triazine, 2,4-bis(dineopentyl 4'- aminobenzalmalonate)-6-(n-butyl 4'-aminobenzoate)-s-triazine, symmetrical triazine screening agents described in patent US 6,225,467, patent application WO 2004/085412 (see compounds 6 and 9) or the document "Symmetrical Triazine Derivatives" IP.COM Journal, IP.COM Inc., West Henrietta, NY, US (20 September 2004), especially 2,4,6-tris(biphenyl)-1 ,3,5-triazines (in particular 2,4,6-tris(biphenyl-4- yl)-1 ,3,5-triazine and 2,4,6-tris(terphenyl)-1 ,3,5-triazine, which is included in patent applications WO 06/035000, WO 06/034982, WO 06/034991 , WO 06/035007, WO 2006/034992 and WO 2006/034985).
Anthranilic derivatives:
An example of a suitable anthranilic derivative includes, but is not limited to, menthyl anthranilate.
Imidazoline derivatives:
An example of a suitable imidazoline derivative includes, but is not limited to, ethylhexyl dimethoxybenzylidene dioxoimidazoline propionate.
Benzalmalonate derivatives:
An example of a suitable Benzalmalonate derivative includes, but is not limited to, polyorganosiloxane containing benzalmalonate functions, for instance polysilicone-15.
4,4-Diarylbutadiene derivatives:
An example of a suitable 4,4-diarylbutadiene derivative includes, but is not limited to, 1 -Dicarboxy(2,2’-dimethylpropyl)-4, 4-diphenyl-butadiene.
Benzoxazole derivatives:
An example of suitable benzoxazole derivative includes, but is not limited to, 2,4-bis[5-(1 -dimethylpropyl)benzoxazol-2-yl-(4-phenyl)imino]-6-(2-ethylhexyl) imino-1 ,3,5-triazine, and mixtures thereof.
Preferably, the oil-soluble organic sunscreen ingredient will be chosen from butyl methoxydibenzoylmethane, ethylhexyl salicylate, ethylhexyl triazone, octocrylene, drometrizole trisiloxane, bis-ethylhexyloxyphenol methoxyphenyl triazine, and mixtures thereof.
The oil-soluble organic sunscreen ingredient is preferably present in the composition according to the invention in an amount of from about 3% to about 25% by weight, preferably in an amount of from about 5% to about 20% by weight, and most preferably about 7% to about 18% by weight, based on the total weight of the composition.
Water-soluble organic sunscreen ingredient
The“water-soluble organic sunscreen ingredient” means any organic compound for screening out UV radiation, which can be fully dissolved in molecular form or miscible in a liquid aqueous phase or which can be dissolved in colloidal form (for example in micellar form) in a liquid aqueous phase.
Non-limiting examples of water-soluble organic sunscreen ingredients useful in the invention include, for example, terephthalylidene dicamphor sulfonic acid (Ecamsule), phenylbenzimidazole sulfonic acid (Ensulizole), benzophenone-4, aminobenzoic acid (PABA), 4-Bis(polyethoxy)-para-aminobenzoic acid polyethoxyethyl ester (PEG-25 PABA), camphor benzalkonium methosulfate, methylene bis-benzotriazolyl tetramethylbutylphenol (Bisoctrizole), disodium phenyl dibenzimidazole tetrasulfonate (Bisdisulizole disodium), and tris-biphenyl triazine; their derivatives and corresponding salts; naphthalene bisimide derivatives such as those described in European patent application EP1990372 A2, the entire contents of which is hereby incorporated by reference; and cinnamido amine cationic quaternary salts and derivatives such as those described in United States Patent 5,601 ,81 1 , the entire contents of which is hereby incorporated by reference, and mixtures thereof.
The salts of the compounds that may be used according to the invention are chosen in particular from salts of alkali metals, for example sodium or potassium; salts of alkaline-earth metals, for example calcium, magnesium or strontium; metal salts, for example zinc, aluminum, manganese or copper; salts of ammonium of formula NH4+; quaternary ammonium salts; salts of organic amines, for instance salts of methylamine, dimethylamine, trimethylamine, triethylamine, ethylamine, 2- hydroxyethylamine, bis(2-hydroxyethyl)amine or tris(2-hydroxyethyl)amine; lysine or arginine salts. Salts chosen from sodium, potassium, magnesium, strontium, copper, manganese or zinc salts are preferably used. The sodium salt is preferably used.
Preferably, the water-soluble organic sunscreen ingredient will be chosen from terephthalylidene dicamphor sulfonic acid, methylene bis-benzotriazolyl tetramethylbutylphenol, and mixtures thereof.
The water-soluble organic sunscreen ingredient is preferably present in the composition according to the invention in an amount of from about 0.1 % to about 10% by weight, preferably in an amount of from about 0.5% to about 8% by weight, and most preferably about 1 % to about 7% by weight, based on the total weight of the composition.
Silica-coated titanium dioxide sunscreen ingredient
The “silica-coated titanium dioxide sunscreen ingredient” means spherical beads which are formed by encapsulating titanium dioxide particles in silica.
Non-limiting examples of silica coated titanium dioxide sunscreen ingredients useful in the invention include, for example, titanium dioxide coated with silica, such as name silica (and) titanium dioxide having a composition of silica:titanium dioxide of about 55:45 and having a particle size from about 2 microns to about 7 microns.
The silica-coated titanium dioxide sunscreen ingredient is preferably present in the composition according to the invention in an amount of from about 1 % to about 10% by weight, preferably in an amount of from about 2% to about 10% by weight, and most preferably about 5% to about 10% by weight, based on the total weight of the composition.
The suitable UV filter system of the present invention comprises terephthalylidene dicamphor sulfonic acid, octocrylene and butyl methoxydibenzoylmethane sulfonic acid.
According to the invention, the concentration of the mixture of sunscreen/UV filters in the system may be between about 3% to about 40%, preferably between about 5% to about 25% and even more preferably between about 7 to about 18% by weight of the total weight of the composition.
Polylactic acid (PLA)
The compositions of the invention comprise porous microparticles of a polylactic acid-based resin, sometimes referred to herein as “polylactic acid microparticles” or“PLA.”
The PLA microparticles may have an enthalpy of fusion of 5 J/g or more, preferably 10 J/g or more, more preferably 20 J/g or more, and most preferably 30 J/g or more. Further, the upper limit is preferably 100 J/g or less, although it is not limited in particular. Enthalpy of fusion refers to a value calculated from a peak area, which shows heat capacity of fusion at approximately 160°C, in a differential scanning calorimetry (DSC) where a temperature is raised to 200°C with the temperature rise of 20°C per minute.
Enthalpy of fusion can be adjusted by controlling the co-polymerization ratio (L/D) between L-lactic acid and D-lactic acid which constitute the polylactic acid- based resin. When the L/D ratio is 95/5 or more, enthalpy of fusion becomes 5 J/g or more and the polylactic acid-based resin becomes crystalline. It is preferred that the co-polymerization ratio of L-lactic acid is high because higher ratios facilitate crystallization. L/D is more preferably 97/3 or more, and most preferably 98/2 or more. L/D is 100/0 or less. Because optical isomers such as L and D have molecular structures that are mirror images of each other and physical properties are not different, enthalpy of fusion remains unchanged when the above-described L/D is substituted with D/L and consequently suitable resins include ones in which L/D is substituted with D/L.
Further, the polylactic acid-based resin may contain copolymerization ingredients other than lactic acid. The other copolymerization ingredient units can be, for example, a multivalent carboxylic acid, a polyhydric alcohol, a hydroxycarboxylic acid or a lactone. Exemplary multivalent carboxylic acids include oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, azelaic acid, sebacic acid, dodecanedioic acid, fumaric acid, cyclohexanedicarboxylic acid, terephthalic acid, isophthalic acid, phthalic acid, 2,6-naphthalenedicarboxylic acid, anthracene dicarboxylic acid, 5- sodium sulfoisophthalic acid and 5-tetrabutyl phosphonium sulfoisophthalic acid. Exemplary polyhydric alcohols include ethylene glycol, propylene glycol, butanediol, heptanediol, hexanediol, octanediol, nonanediol, decanediol, 1 ,4- cyclohexanedimethanol, neopentyl glycol, glycerin, pentaerythritol, bisphenol A, an aromatic polyhydric alcohol produced by an addition reaction of ethylene oxide to a bisphenol, diethylene glycol, triethylene glycol, polyethylene glycol, polypropylene glycol and polytetramethylene glycol. Exemplary hydroxycarboxylic acids include glycolic acid, 3-hydroxybutyric acid, 4-hydroxybutyric acid, 4-hydroxyvaleric acid, 6- hydroxycaproic acid and hydroxybenzoic acid. Exemplary lactones include glycolide, e-caprolactone glycolide, e-caprolactone, b-propiolactone, d-butyrolactone, b- butyrolactone, g-butyrolactone, pivalolactone and d-valerolactone. The volume content of the other copolymerization units is preferably 30 mol % or less, more preferably 20 mol % or less, further more preferably 10 mol % or less, most preferably 5 mol % or less, relative to the total monomer units of the polylactic acid-based resin as 100 mol%.
Although molecular mass and molecular mass distribution of the polylactic acid-based resin are not limited in particular, the lower limit of weight average molecular mass of the polylactic acid-based resin is preferably 10,000 or more, more preferably 50,000 or more, further more preferably 100,000 or more, most preferably 200,000 or more. Further, although not limited in particular, the upper limit of weight average molecular mass is preferably 1 ,000,000 or less. The weight average molecular mass referred to herein is weight average molecular mass in terms of polymethyl methacrylate (PMMA), measured by gel permeation chromatography (GPC) using hexafluoroisopropanol as a solvent.
The PLA microparticles may have a number average particle diameter of 90 pm or less, preferably 50 pm or less, more preferably 30 pm or less. This improves smoothness. Further, in uses such as cosmetics, because coagulation of particles tends to occur when the number average particle diameter is too small, the lower limit of the number average particle diameter is generally 1 pm or more, preferably more than 1 pm, more preferably 2 pm or more, most preferably 3 pm or more.
The particle diameter distribution index is preferably 2 or less in order to improve flow of the particles and impart a smoother touch. The upper limit of the particle diameter distribution index is preferably 1 .5 or less, more preferably 1 .3 or less, most preferably 1 .2 or less. Further, the lower limit is 1 in theory.
The above-described number average particle diameter of polylactic acid-based resin microparticles having porous shapes can be calculated by measuring diameters of 100 random particles in a scanning electron microscope image and computing the arithmetic average thereof. If a shape of a particle in the SEM image is not a perfect circle, for example, an ellipse, the maximum diameter of the particle is used as its diameter. To measure the particle diameter precisely, the measurement is carried out with a magnification of at least 1000 times or more, preferably with a magnification of 5000 times or more.
The particle diameter distribution index is calculated on the basis of the conversion equations described below, using measurements of the particle diameters obtained by measurement described above:
Figure imgf000015_0001
mi m&viBn
wherein Ri: particle diameter of single particle, n: the number of measurements (=100), Dn: number average particle diameter, Dv: volume average particle diameter, PDI: particle diameter distribution index.
Although the actual amount of pores in a porous microparticle of polylactic acid-based resin is difficult to measure directly, it is possible to use linseed oil absorption capacity as an indirect index, which is defined in pigment test methods such as Japan Industrial Standards (Refined Linseed Oil Method, JIS K 5101 ).
In particular, in the uses such as cosmetics and paints, higher linseed oil capability is preferable, and the lower limit of linseed oil capability is preferably 90 mL/100 g or more, more preferably 100 mL/100 g or more, further more preferably 120 mL/100 g or more, particularly preferably 150 mL/100 g or more, remarkably preferably 200 mL/100 g or more, most preferably 300 mL/100 g or more. The upper limit of linseed oil absorption capability is preferably 1000 mL/100 g or less.
Further, it is preferred that the above-described porous microparticles of polylactic acid-based resin have enthalpy of fusion of 5 J/g or more. Higher enthalpy of fusion brings higher crystallization tendency and, as a result, heat resistance and durability tend to become high. The lower limit of enthalpy of fusion is preferably 10 J/g or more, more preferably 20 J/g or more, further more preferably 30 J/g or more. Further, the upper limit is preferably 100 J/g or less. Enthalpy of fusion can be calculated from an area of peak showing thermal capacity of fusion at approximately 160°C in Differential Scanning calorimetry (DSC) in which a temperature is raised to 200°C with a temperature rise of 20°C per minute.
Sphericity of the above-described porous microparticles of polylactic acid-based resin is preferably 80 or more, more preferably 85 or more, furthermore preferably 90 or more, particularly preferably 92 or more, most preferably 95 or more. Further, in theory, the upper limit is 100. When sphericity is within the above-described range, it becomes possible to achieve an improvement in quality such as slidability. The sphericity is calculated by observing particles by a scanning electron microscope, measuring both the longest diameters and the shortest diameters of 30 random particles and subsequently substituting the measurements into the equation described below:
Figure imgf000016_0001
wherein S: Sphericity, n: the number of measurements (=30), Ds: the shortest diameter of single particle, DL: the longest diameter of single particle.
MATTIFYING POWDER
The term“mattifying powder” means a powder which absorbs sebum and provides a mattifying effect to the skin.
Non-limiting examples of mattifying powders useful in the invention include, for example, modified starches, polyamide powders, hydrophobic silica aerogel particles, acrylic polymer powders, elastomeric silicone powders, clays, and mixtures thereof.
Modified starches useful in the invention include, for example, those known under the INCI names aluminum starch octenylsuccinate, sodium starch octenylsuccinate, calcium starch octenylsuccinate, and mixtures thereof.
Polyamide powders useful in the invention include, for example, those known under the INCI name nylon-12, nylon-6, and mixtures thereof.
The term "hydrophobic silica" means any silica whose surface is treated with silylating agents, for example halogenated silanes such as alkylchlorosilanes, siloxanes, in particular dimethylsiloxanes such as hexamethyldisiloxane, or silazanes, so as to functionalize the OH groups with silyl groups Si-Rn, for example trimethylsilyl groups.
Hydrophobic silica aerogel particles useful in the invention are preferably particles surface-modified with trimethylsilyl groups known under the INCI name silica silylate and include, for example, the aerogel, the particles of which have a mean size of about 1000 microns and a specific surface area per unit of mass ranging from 600 to 800 m2/g. A hydrophobic silica aerogel particle is the aerogel, the particles of which have a mean size ranging from 5-15 microns and a specific surface area per unit of mass ranging from 600 to 800 m2/g.
Acrylic polymer powders useful in the invention include, for example, acrylic polymer powders such as methyl methacrylate crosspolymer.
Clays useful in the invention include, for example, clays of the smectite family such as montmorillonites, hectorites, bentonites, beidellites and saponites, and also of the vermiculite, stevensite and chlorite families. Non-limiting examples of clays usefil in the invention include, for example, synthetic hectorites (also known as laponites), these products are sodium magnesium silicates and in particular sodium lithium magnesium silicates; bentonites, magnesium aluminium silicates, especially hydrated, or calcium silicates and especially the product in synthetic form.
Most preferably, the mattifying powders will be chosen from aluminum starch octenylsuccinate, nylon-12, silica silylate, methyl methacrylate crosspolymer, and mixtures thereof.
ADDITIONAL INGREDIENTS
In addition to the essential components described hereinbefore, the composition of the invention may further comprise any usual cosmetically acceptable ingredient, which may be chosen especially from such as additional sunscreens, perfume/fragrance, preserving agents, solvents, actives, surfactants, fatty compounds, vitamins, fillers, silicones, polymers, pigments and mixtures thereof.
A person skilled in the art will take care to select the optional additional ingredients and/or the amount thereof such that the advantageous properties of the composition according to the invention are not, or are not substantially, adversely affected by the envisaged addition.
Non-limiting example of preserving agent which can be used in accordance with the invention include phenoxyethanol.
Suitable fillers of the invention could be as examples of oil-absorbing fillers: mica, silica, zea may (corn) starch, magnesium oxide, nylon-12, nylon-66, cellulose, polyethylene, talc, talc (and) methicone, talc (and) dimethicone, perlite, sodium silicate, pumice, ptfe, polymethyl methacrylate, oryza sativa (rice) starch, aluminum starch octenylsuccinate, potato starch modified, alumina, silica silylate, calcium sodium borosilicate, magnesium carbonate, hydrated silica, dimethicone/vinyl dimethicone crosspolymer, sodium carboxylmethyl starch.
Suitable solvents include, but are not limited to water, alcohols, glycols and polyols such as glycerin, caprylyl glycol, pentylene glycol, propylene glycol, butylene glycol, and mixtures thereof.
In various embodiments, the solvent is present in a concentration from about 15 to 00% by weight, or from about 20 to about 80% by weight, or from about 30 to about 70% by weight, or from about 35 to about 75% by weight, or preferably from about 40 to about 70% by weight, and more preferably from about 45 to about 65% by weight, including ranges and sub-ranges there between, based on the total weight of the combinations and/or compositions of the present disclosure.
Suitable additional actives include, but are not limited to, disodium EDTA, triethanolamine, and mixtures thereof.
In addition to the emulsifying agents of the present disclosure, surfactants may also be used in the compositions of the present invention non-limiting examples of surfactants suitable for use are fatty acids, glyceryl esters in addition to glyceryl stearate, alkoxylated fatty alcohols, such as stearic acid, laureth-12, glyceryl isostearate, disodium stearoyl glutamate, potassium cetyl phosphate, poloxamer 338, sodium methyl stearoyl taurate and mixtures thereof.
Exemplary fat or oil materials include, but are not limited to, esters, fatty acids, synthetic oils, and hydrocarbons/paraffins, such as stearyl alcohol, myristic acid, palmitic acid silicones mineral oil, plant/vegetable oils, and mixtures thereof.
Non-limiting example of vitamins suitable for the composition of the present invention includes tocopherol.
Also, non-limiting example of fatty compounds suitable for the present invention include diisopropyl sebacate, isononyl isononanoate and stearyl alcohol.
Exemplary of polymers, include, but not limited to, ammonium acryloyldimethyltaurate/vp copolymer and acrylates/Cio-30 alkyl acrylate crosspolymer.
The additional ingredients may represent from 60% to 85%, such as from 60% to 82% or such as from 65 to 80% by weight of the total weight of the composition.
By way of non-limiting illustration, the invention will now be described with reference to the following examples.
EXAMPLES
Examples 1 to 4
A suitable composition of the invention is as Examples 1 to 3 and Example 4 is considered the closest prior art, as follows:
Figure imgf000018_0001
Figure imgf000019_0001
Figure imgf000020_0001
Figure imgf000021_0001
A stability test was performed with the compositions of Ex. 1 (comprising the surfactant system) and Ex. 2 (without the surfactant system) during 2 months. The compositions were evaluated at a room temperature and at 45QC.
Based on the comparison of such compositions, it was possible to observe a superior stability and robustness of the composition of the present invention (comprising the surfactant system) in view of the composition of the state of the art (without the surfactant system), as showed by FIG. 1.
Example 5
A non-limiting example regarding the preparation of the composition of Example 1 , could be as follows:
Step (A): The aqueous phase comprising water, preservatives and surfactants is mixed at a room temperature until achieve a solution;
Step (B): The thickening polymers are added to the aqueous phase by mixing well;
Step (C): Subsequently, the polymer is neutralized;
Step (D): The oily phase comprising the PLA, UV filter system and mattifying powder is heated up to 75°C mixing well;
Step (E): The emulsion is achieved by the addition of oily phase on the neutralized aqueous phase with a cold bath, and
Step (F): Adding the fillers to the emulsion of Step (E) by mixing well.

Claims

SET OF CLAIMS
1 . A surfactant system comprising:
(i) from about 1 to about 30% by weight of a mixture of at least three stearol derivatives compounds;
(ii) from about 0.05 to about 10% by weight of a phosphate surfactant;
(iii) from about 0.05 to 10% by weight of sodium salt of the stearic acid amide.
2. Surfactant system, according to the proceeding claim, wherein the mixture of at least three stearol derivatives compounds comprises stearic acid, glyrecyl stearate and PEG-100 stearate and stearyl alcohol.
3. Surfactant system, according to any one of the proceeding claims, wherein the mixture of at least three stearol derivatives compounds is ranging from about 2.5 to about 8% by weight, or more preferably from about 3 to about 6% by weight, including all ranges and sub-ranges there between, relative to the total weight of the composition.
4. Surfactant system, according to any one of the proceeding claims, wherein the mixture of at least three stearol derivatives compounds employs a first surfactant in an amount preferably ranging from about 0.1 to about 10% by weight and preferably from about 0.3 to about 5% by weight, or more preferably from about 0.5 to about 3% by weight, including all ranges and sub-ranges there between, relative to the total weight of the composition.
5. Surfactant system, according to any one of the proceeding claims, wherein the mixture of at least three stearol derivatives compounds employs a second surfactant in an amount preferably ranging from about 0.05 to about 10% by weight and preferably from about 0.1 to about 6% by weight, or more preferably from about 0.2 to about 3% by weight, including all ranges and sub-ranges therebetween, relative to the total weight of the composition.
6. Surfactant system, according to any one of the proceeding claims, wherein the mixture of at least three stearol derivatives compounds employs a third surfactant in an amount preferably ranging from about 0.05 to about 10% by weight and preferably from about 0.1 to about 5% by weight, or more preferably from about 0.1 to about 2% by weight, including all ranges and sub-ranges therebetween, relative to the total weight of the composition.
7. Surfactant system, according to any one of the proceeding claims, wherein the phosphate surfactant is selected from the group comprising monoalkyl phosphates, potassium cetyl phosphate, dialkyl phosphates, salts of monoalkyl phosphates, salts of dialkyl phosphates, and mixtures thereof.
8. Surfactant system, according to any one of the proceeding claims, wherein the phosphate surfactant is present in the surfactant system in a range of from about 0.1 to about 5% by weight, or more preferably from about 0.2 to about 3% by weight, including all ranges and sub-ranges therebetween, relative to the total weight of the composition.
9. Surfactant system, according to any one of the proceeding claims, wherein the sodium salt of the stearic acid amide is selected from sodium methyl stearoyl taurate.
10. Surfactant system, according to any one of the proceeding claims, wherein the sodium salt of the stearic acid amide is present in the composition in a range of from about 0.1 to about 4% by weight, or more preferably from about 0.2 to about 1 % by weight, including all ranges and sub-ranges therebetween, relative to the total weight of the composition.
1 1 . A sunscreen composition comprising:
(a) a surfactant system, as defined in any one of the proceeding claims;
(b) UV filters;
(c) a polylactic acid-based resin (PLA); and
(d) a mattifying powder.
12. Sunscreen composition, according to the preceding claim, wherein the surfactant system in the sunscreen composition of the invention ranges from about 0.2 to about 8% by weight, or from about 0.3 to about 7% by weight, from about 0.5 to about 5% by weight or from about 0.6 to about 4.5% by weight, including all ranges and sub-ranges therebetween, relative to the total weight of the composition.
13. Sunscreen composition, according to any one of claims 10 to 1 1 , wherein the UV filters are selected from oil-soluble organic ingredient, water-soluble organic sunscreen ingredient and silica-coated titanium dioxide sunscreen ingredient.
14. Sunscreen composition, according to any one of claims 10 to 1 2, wherein the UV filters in the sunscreen composition of the invention ranges from about 3% to about 40% by weight, preferably in an amount of from about 5% to about 25% by weight, and most preferably about 7% to about 18% by weight, based on the total weight of the composition.
15. Sunscreen composition, according to any one of claims 10 to 13, wherein the polylactic acid-based resin (PLA) in the sunscreen composition of the invention ranges from about 0.1 to about 3% by weight, or from about 0.2 to about 2% by weight, or from about 0.1 to about 1 % by weight, including all ranges and sub ranges therebetween, relative to the total weight of the composition.
16. Sunscreen composition, according to any one of claims 10 to 14, wherein the mattifying powder is selected from modified starches, polyamide powders, hydrophobic silica aerogel particles, acrylic polymer powders, elastomeric silicone powders, clays, and mixtures thereof.
17. Sunscreen composition, according to any one of claims 10 to 1 5, wherein the amount of the mattifying agent in the sunscreen composition of the invention ranges from about 0.01 % to about 10% by weight, preferably in an amount of from about 0.1 % to about 5% by weight, and most preferably about 0.5% to about 4% by weight, based on the total weight of the composition.
18. Sunscreen composition, according to any one of claims 10 to 16, wherein it further comprises cosmetically acceptable ingredients selected from additional sunscreens, perfume/fragrance, preserving agents, solvents, actives, surfactants, fatty compounds, vitamins, polymers, fillers, silicones and mixtures thereof.
19. Sunscreen composition, according to any one of claims 10 to 17, wherein it presents a Sun Protection Factor 50.
20. Sunscreen composition, according to any one of claims 10 to 18, wherein it presents a Sun Protection Factor 60.
21 . Sunscreen composition, according to any one of claims 10 to 19, wherein it presents a Sun Protection Factor 70.
22. Sunscreen composition, according to any one of claims 10 to 20, wherein it presents a Sun Protection Factor 80.
23. Sunscreen composition, according to any one of claims 10 to 21 , wherein it is in the form of an O/W emulsion.
24. Sunscreen composition, according to any one of claims 10 to 22, wherein the pH is within the range of about 6.0 to about 7.6, more preferably, of about 6.5. wherein it is for the manufacture of a sunscreen composition.
26. Use of a sunscreen composition, as defined in any one of claims 10 to 23, wherein it is for the manufacture of a product to be used as sunscreen daily product.
27. Use, according to claim 26, wherein it is for the manufacture of a product with presents a high level of UV-protection in order to protect the keratin fibers from the damages of the sun, easy application, good spreadability and less silicon effect, less white film, less shine, which does not run on high temperature in the face, has an imperceptible touch, gives the ideal balance between hydration and oil control, reduces impurities accumulation, reinforces the barrier against pollution, leaves the facial skin breathing, combines high protection with smoothness to the skin, sweat resistant, prepare the skin for the make-up, renew the skin quality, let the skin breathe, purified skin sensation and soothing effect to the skin and is stable over the time.
28. Use, according to one of claims 26 to 27, wherein the composition is in the form of an O/W emulsion.
29. A process of manufacturing the sunscreen composition, as defined in any one of claims 10 to 24, comprising the following steps:
Step (A): The aqueous phase comprising water, preservatives and surfactants is mixed at a room temperature until achieve a solution;
Step (B): The thickening polymers are added to the aqueous phase by mixing well;
Step (C): Subsequently, the polymer is neutralized;
Step (D): The oily phase comprising the PLA, UV filter system and mattifying powder is heated up to 75°C mixing well;
Step (E): The emulsion is achieved by the addition of oily phase on the neutralized aqueous phase with a cold bath, and
Step (F): Adding the fillers to the emulsion of Step (E) by mixing well.
PCT/BR2018/050212 2018-06-28 2018-06-28 Surfactant system and sunscreen composition comprising it WO2020000068A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR112020019792-0A BR112020019792B1 (en) 2018-06-28 2018-06-28 COMPOSITION OF SOLAR FILTER AND USE OF A COMPOSITION
PCT/BR2018/050212 WO2020000068A1 (en) 2018-06-28 2018-06-28 Surfactant system and sunscreen composition comprising it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BR2018/050212 WO2020000068A1 (en) 2018-06-28 2018-06-28 Surfactant system and sunscreen composition comprising it

Publications (1)

Publication Number Publication Date
WO2020000068A1 true WO2020000068A1 (en) 2020-01-02

Family

ID=62873105

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2018/050212 WO2020000068A1 (en) 2018-06-28 2018-06-28 Surfactant system and sunscreen composition comprising it

Country Status (2)

Country Link
BR (1) BR112020019792B1 (en)
WO (1) WO2020000068A1 (en)

Citations (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2463264A (en) 1942-12-23 1949-03-01 Ciba Ltd Derivatives of cyclic amidines and process of making same
US5166355A (en) 1991-02-04 1992-11-24 Fairmount Chemical Co., Inc. Process for preparing substituted 2,2'-methylene-bis-[6-(2H-benzotriazol-2-yl)-4-hydrocarbyl-phenols]
WO1993004665A1 (en) 1991-08-29 1993-03-18 L'oreal Filtering cosmetic composition containing a liposoluble filter polymer with hydrocarbonated structure and a filter silicone
US5237071A (en) 1991-01-22 1993-08-17 Fairmount Chemical Company, Inc. Process for preparing 2,2'-methylene-bis(6-(2H-benzotriazol-2-yl)-4-hydrocarbyl phenols)
EP0669323A1 (en) 1994-02-24 1995-08-30 Haarmann & Reimer Gmbh Utilization of benzazols as UV-absorbers, new benzazoles and process for their preparation
US5601811A (en) 1994-08-01 1997-02-11 Croda, Inc. Substantive water-soluble cationic UV-absorbing compounds
GB2303549A (en) 1995-07-22 1997-02-26 Ciba Geigy Ag Micronising organic UV absorbers with alkyl polyglucosides
US5624663A (en) 1987-08-28 1997-04-29 L'oreal Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates
EP0832642A2 (en) 1996-09-13 1998-04-01 3V SIGMA S.p.A Derivatives of Benzoxazole useful as uv filters
DE19726184A1 (en) 1997-06-20 1998-12-24 Beiersdorf Ag Oil-in-water or multiple emulsion with high concentration of suspended UVB filter
EP0893119A1 (en) 1997-07-26 1999-01-27 Ciba SC Holding AG UV-protection formulation
DE19746654A1 (en) 1997-08-13 1999-02-18 Basf Ag Use of 4,4-di:aryl-butadiene derivatives as photostable UV filter compounds
DE19755649A1 (en) 1997-12-15 1999-06-17 Basf Ag Use of 4,4-diarylbutadienes as photostable UV filters in cosmetics
EP0967200A1 (en) 1998-06-26 1999-12-29 Basf Aktiengesellschaft 4,4-Diarylbutadienes as water soluble, photostable UV-filters for cosmetic and pharmaceutical preparations
DE19855649A1 (en) 1998-12-03 2000-06-08 Basf Ag Dimeric alpha-alkyl-styrene derivatives as photostable UV filters in cosmetic and pharmaceutical preparations
EP1008586A1 (en) 1998-12-11 2000-06-14 Basf Aktiengesellschaft Oligomeric diarylbutadienes
EP1027883A2 (en) 1999-01-11 2000-08-16 3V SIGMA S.p.A Combinations of sunscreen agents with UV-A and UV-B filtering properties
US6225467B1 (en) 2000-01-21 2001-05-01 Xerox Corporation Electroluminescent (EL) devices
EP1133980A2 (en) 2000-03-15 2001-09-19 Basf Aktiengesellschaft Use of combinations of photoprotectors comprising as essential components aminosubstituted hydroxybenzophenones as photostable UV-filters in cosmetic and pharmaceutical preparations
EP1133981A2 (en) 2000-03-15 2001-09-19 Basf Aktiengesellschaft Use of light-screening combinations containing 4,4-Diarylbutadienes as photostable UV-filters in cosmetic and pharmaceutic preparations
EP1300137A2 (en) 2001-10-02 2003-04-09 3V SIGMA S.p.A Combinations of sunscreens
DE10162844A1 (en) 2001-12-20 2003-07-03 Beiersdorf Ag Cosmetic and dermatological light protection formulations containing bis-resorcinyltriazine derivatives and benzoxazole derivatives
WO2004006878A1 (en) 2002-07-10 2004-01-22 Ciba Specialty Chemicals Holding Inc. Merocyanine derivatives for cosmetic use
WO2004085412A2 (en) 2003-03-24 2004-10-07 Ciba Specialty Chemicals Holding Inc. Symmetrical triazine derivatives
WO2005058269A1 (en) 2003-12-17 2005-06-30 Ciba Specialty Chemicals Holding Inc. Merocyanine derivatives for cosmetic use
WO2006032741A1 (en) 2004-09-20 2006-03-30 L'oréal Silane merocyanine sulphone derivatives; photoprotecting compositions containing same; use thereof as uv filter
WO2006035000A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag Sun protection emulsion comprising a high fraction of sun protection filter pigments
WO2006035007A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag Cosmetic light-block preparation made from micropigments
WO2006034982A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag Light-block concentrate with organic micropigments
WO2006034991A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag W/o emulsion comprising uv filter pigments
WO2006034992A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag Cosmetic sunscreen emulsions containing organic micropigments
WO2006034985A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag O/w emulsion comprising inorganic uv filter pigments and alkyl sulfate
EP1990372A2 (en) 2007-05-09 2008-11-12 Ciba Holding Inc. Water soluble UV filters
JP2013071920A (en) * 2011-09-28 2013-04-22 Kose Corp Oil-in-water emulsion cosmetic
WO2017029807A1 (en) * 2015-08-20 2017-02-23 L'oreal Composition comprising a hydrophobically modified inuline and a polyether modified silicone
EP3315116A1 (en) * 2016-10-28 2018-05-02 Cyberderm Laboratories Inc. Topical sunscreen composition, method of preparation, and use thereof

Patent Citations (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2463264A (en) 1942-12-23 1949-03-01 Ciba Ltd Derivatives of cyclic amidines and process of making same
US5624663A (en) 1987-08-28 1997-04-29 L'oreal Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates
US5237071A (en) 1991-01-22 1993-08-17 Fairmount Chemical Company, Inc. Process for preparing 2,2'-methylene-bis(6-(2H-benzotriazol-2-yl)-4-hydrocarbyl phenols)
US5166355A (en) 1991-02-04 1992-11-24 Fairmount Chemical Co., Inc. Process for preparing substituted 2,2'-methylene-bis-[6-(2H-benzotriazol-2-yl)-4-hydrocarbyl-phenols]
WO1993004665A1 (en) 1991-08-29 1993-03-18 L'oreal Filtering cosmetic composition containing a liposoluble filter polymer with hydrocarbonated structure and a filter silicone
EP0669323A1 (en) 1994-02-24 1995-08-30 Haarmann & Reimer Gmbh Utilization of benzazols as UV-absorbers, new benzazoles and process for their preparation
US5601811A (en) 1994-08-01 1997-02-11 Croda, Inc. Substantive water-soluble cationic UV-absorbing compounds
GB2303549A (en) 1995-07-22 1997-02-26 Ciba Geigy Ag Micronising organic UV absorbers with alkyl polyglucosides
EP0832642A2 (en) 1996-09-13 1998-04-01 3V SIGMA S.p.A Derivatives of Benzoxazole useful as uv filters
DE19726184A1 (en) 1997-06-20 1998-12-24 Beiersdorf Ag Oil-in-water or multiple emulsion with high concentration of suspended UVB filter
EP0893119A1 (en) 1997-07-26 1999-01-27 Ciba SC Holding AG UV-protection formulation
DE19746654A1 (en) 1997-08-13 1999-02-18 Basf Ag Use of 4,4-di:aryl-butadiene derivatives as photostable UV filter compounds
DE19755649A1 (en) 1997-12-15 1999-06-17 Basf Ag Use of 4,4-diarylbutadienes as photostable UV filters in cosmetics
EP0967200A1 (en) 1998-06-26 1999-12-29 Basf Aktiengesellschaft 4,4-Diarylbutadienes as water soluble, photostable UV-filters for cosmetic and pharmaceutical preparations
DE19855649A1 (en) 1998-12-03 2000-06-08 Basf Ag Dimeric alpha-alkyl-styrene derivatives as photostable UV filters in cosmetic and pharmaceutical preparations
EP1008586A1 (en) 1998-12-11 2000-06-14 Basf Aktiengesellschaft Oligomeric diarylbutadienes
EP1027883A2 (en) 1999-01-11 2000-08-16 3V SIGMA S.p.A Combinations of sunscreen agents with UV-A and UV-B filtering properties
US6225467B1 (en) 2000-01-21 2001-05-01 Xerox Corporation Electroluminescent (EL) devices
EP1133980A2 (en) 2000-03-15 2001-09-19 Basf Aktiengesellschaft Use of combinations of photoprotectors comprising as essential components aminosubstituted hydroxybenzophenones as photostable UV-filters in cosmetic and pharmaceutical preparations
EP1133981A2 (en) 2000-03-15 2001-09-19 Basf Aktiengesellschaft Use of light-screening combinations containing 4,4-Diarylbutadienes as photostable UV-filters in cosmetic and pharmaceutic preparations
EP1300137A2 (en) 2001-10-02 2003-04-09 3V SIGMA S.p.A Combinations of sunscreens
DE10162844A1 (en) 2001-12-20 2003-07-03 Beiersdorf Ag Cosmetic and dermatological light protection formulations containing bis-resorcinyltriazine derivatives and benzoxazole derivatives
WO2004006878A1 (en) 2002-07-10 2004-01-22 Ciba Specialty Chemicals Holding Inc. Merocyanine derivatives for cosmetic use
WO2004085412A2 (en) 2003-03-24 2004-10-07 Ciba Specialty Chemicals Holding Inc. Symmetrical triazine derivatives
WO2005058269A1 (en) 2003-12-17 2005-06-30 Ciba Specialty Chemicals Holding Inc. Merocyanine derivatives for cosmetic use
WO2006032741A1 (en) 2004-09-20 2006-03-30 L'oréal Silane merocyanine sulphone derivatives; photoprotecting compositions containing same; use thereof as uv filter
WO2006035000A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag Sun protection emulsion comprising a high fraction of sun protection filter pigments
WO2006035007A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag Cosmetic light-block preparation made from micropigments
WO2006034982A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag Light-block concentrate with organic micropigments
WO2006034991A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag W/o emulsion comprising uv filter pigments
WO2006034992A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag Cosmetic sunscreen emulsions containing organic micropigments
WO2006034985A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag O/w emulsion comprising inorganic uv filter pigments and alkyl sulfate
EP1990372A2 (en) 2007-05-09 2008-11-12 Ciba Holding Inc. Water soluble UV filters
JP2013071920A (en) * 2011-09-28 2013-04-22 Kose Corp Oil-in-water emulsion cosmetic
WO2017029807A1 (en) * 2015-08-20 2017-02-23 L'oreal Composition comprising a hydrophobically modified inuline and a polyether modified silicone
EP3315116A1 (en) * 2016-10-28 2018-05-02 Cyberderm Laboratories Inc. Topical sunscreen composition, method of preparation, and use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] MINTEL; 7 March 2018 (2018-03-07), ANONYMOUS: "Hydration Body Sunscreen SPF 70", XP055513286, retrieved from www.gnpd.com Database accession no. 5496659 *

Also Published As

Publication number Publication date
BR112020019792A2 (en) 2021-01-05
BR112020019792B1 (en) 2023-02-07

Similar Documents

Publication Publication Date Title
US20200261748A1 (en) Photoprotective compositions comprising an aqueous phase and a low melting point apolar wax
JP7436529B2 (en) Cosmetic emulsions containing amphoteric surfactants and lipophilic polymers
CN108472515B (en) Photoprotective cosmetic composition and method for obtaining same
CN107847414B (en) Composition comprising a UV screening agent, an anionically crosslinked hydrophilic polymer, a surfactant having an HLB less than or equal to 5, and a siloxane copolymer
WO2014009097A1 (en) Cosmetic composition containing screening composite particles
WO2013049599A2 (en) Personal compositions with silicone emulsifier-free natural emulsifier system
WO2014111562A1 (en) Cosmetic or dermatological emulsion comprising a merocyanine and an emulsifying system containing an alkali metal salt of a phosphoric acid ester of a fatty alcohol
JP2007023031A (en) Sunlight-protecting composition comprising aqueous phase and low-melting apolar wax
WO2013049580A2 (en) Personal compositions with silicone emulsifier-free natural emulsifier system
EP3829533B1 (en) Sunscreen composition, use of the sunscreen composition and process of manufacturing the sunscreen composition
FR2986424A1 (en) Composition comprising UV filter system, used to care and make up human keratin materials, comprises oil phase comprising polar oil and silicon s-triazine substituted by alkylaminobenzoates groups, and hydrophobic silica aerogel particles
JP5792170B2 (en) Composition comprising at least one lipophilic 2-hydroxybenzophenone screening agent and silicon s-triazine substituted with at least two alkylaminobenzoate groups
EP2945609B1 (en) Anhydrous cosmetic or dermatological composition comprising a merocyanine and an oily phase
WO2006005630A1 (en) Aqueous photoprotective composition comprising hydrophilic metal oxide nanopigments and a polyalkylene glycol of low molecular mass; uses
WO2020000068A1 (en) Surfactant system and sunscreen composition comprising it
CN110831569B (en) Photoprotective compositions
WO2020163928A1 (en) Sunscreen composition, use of the sunscreen composition and process of manufacturing the sunscreen composition
CN113242730B (en) Fluid photoprotective compositions
JP7218158B2 (en) Water-in-oil emulsified cosmetics
US20220241159A1 (en) Cosmetic compositions in a soft-solid format comprising a hydrophobic powder selected from silica aerogel and polylactic acid, starch and an uv-filter system
WO2023235942A1 (en) Cosmetic sunscreen composition and use of a cosmetic sunscreen composition
WO2019096960A1 (en) Compositions comprising at least one acrylic polymer and at least one insoluble organic screening agent
WO2019210376A1 (en) Sunscreen compositions
BR112020011082A2 (en) sun protection composition, use of a composition and method to manufacture the composition
WO2018086005A1 (en) Composition with cooling sensation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18739448

Country of ref document: EP

Kind code of ref document: A1

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112020019792

Country of ref document: BR

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 112020019792

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20200928

122 Ep: pct application non-entry in european phase

Ref document number: 18739448

Country of ref document: EP

Kind code of ref document: A1